healthcare disparities
As Alzheimer's Dx Comparison Study Wraps Up, Researchers Plan to Add Genomic, Proteomic Profiling
Premium
Results from the Global Alzheimer's Platform cross-sectional study are expected in July 2023 with a second longitudinal study to be finished by the end of 2024.
California Governor Vetoes Biomarker Test Coverage Bill
The bill would have mandated insurance coverage for biomarker tests supported by medical and scientific evidence but not the prices that insurers would have to pay.
Pediatric Patients Face Barriers Receiving Exome Sequencing From Insurance, Scheduling Delays
Premium
A recent analysis found that it can take between five days and more than a year from when testing is first considered to sample collection.
Tempus, Lilly Ink Partnership to Offer No-Cost NGS for Advanced NSCLC Patients
Lilly will cover the cost of Tempus' broad-based sequencing tests for advanced non-small cell lung cancer patients to improve biomarker testing access.
The study looked at Black patients with the APOL1 genotype, a signifier of increased risk of kidney failure.
Sep 27, 2021